FDA approves drug from genetically engineered material

0 Shares

FDA approves a drug derived from genetically engineered animal milkThe Food and Drug Administration has issued its first approval for a medication that is produced using material from genetically engineered (GE) animals.

ATryn, as the drug is known, is an anticoagulant used for the prevention of blood clots in patients with a rare disease known as hereditary antithrombin (AT) deficiency.

It is formulated as a protein derived from the milk of goats whose genes have been manipulated by introducing a segment of DNA (called a recombinant DNA or rDNA) with instructions to produce human antithrombin in its milk.

Antithrombin naturally occurs in healthy people and prevents blood from clotting.

To preempt the expected criticism from the natural products industry, the FDA quoted scientists from the Center for Veterinary Medicine who said that based on their observations of seven generations of the GE goats they have not discovered any adverse effects from the rDNA or its expression.

According to the National Alliance for Trombosis and Trombophilia, about 1 in 5,000 Americans has AT deficiency, and these patients are at high risk for clotting during surgery and childbirth.

Until now, the only AT drug available in the U.S. was derived from human blood donors.

ADNFCR-1961-ID-19060519-ADNFCR

Personal Liberty News Desk

Join the Discussion

Comment Policy: We encourage an open discussion with a wide range of viewpoints, even extreme ones, but we will not tolerate racism, profanity or slanderous comments toward the author(s) or comment participants. Make your case passionately, but civilly. Please don't stoop to name calling. We use filters for spam protection. If your comment does not appear, it is likely because it violates the above policy or contains links or language typical of spam. We reserve the right to remove comments at our discretion.